Form 25-NSE/A - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: [Amend]
SEC Accession No. 0001354457-25-001190
Filing Date
2025-11-28
Accepted
2025-11-28 13:00:17
Documents
2
Effectiveness Date
2025-11-28

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 25-NSE/A  
1 primary_doc.xml 25-NSE/A 1075
2 lixtw-form25.txt EX-99.25 111
  Complete submission text file 0001354457-25-001190.txt   3096
Mailing Address 433 PLAZA REAL SUITE 275 BOCA RATON FL 33432
Business Address 433 PLAZA REAL SUITE 275 BOCA RATON FL 33432 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Subject) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE/A | Act: 34 | File No.: 333-248588 | Film No.: 251534320
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address Office of General Counsel 805 King Farm Blvd. ROCKVILLE MD 20850
Business Address One Liberty Plaza New York NY 10006 301-978-4144
Nasdaq Stock Market LLC (Filed by) CIK: 0001354457 (see all company filings)

EIN.: 521165937 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 25-NSE/A